Company: PTHS
Filing Date: 2025-11-25
Form Type: DEF 14A
Source: 0001753926-25-001827
Chunk: 8

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-11-25
Form: DEF 14A
Chunk 8
---
 upon the exercise of stock options held by Mr. Greenleaf, which are exercisable 
 for shares of Common Stock at a price of $13.50 per share and an RSU for 12,739 shares.                                         |
| (5) | For Mr. Baxter,                                                                                                                 
 includes 9,705 shares of Common Stock issuable upon the exercise of stock options held by Mr. Baxter, which are exercisable     
 for shares of Common Stock at a price of $13.50 per share and an RSU for 3,185 shares.                                          |
| (6) | For Mr. Davis, includes                                                                                                         
 3,334 shares of Common Stock issuable upon the exercise of stock options held by Mr. Davis, which are exercisable for shares    
 of Common Stock at a price of $226.80 per share, 2,223 shares of Common Stock issuable upon the exercise of stock options       
 held by Mr. Davis, which are exercisable for shares of Common Stock at a price of $226.80 per share, 9,705 shares of Common     
 Stock issuable upon the exercise of a stock option held by Mr. Davis, which are exercisable for shares of Common Stock at       
 a price of $13.50 per share, an RSU for 12,982 shares, an RSU for 3,185 shares and an additional 29,167 shares of Common Stock  
 issued in a private placement in full satisfaction of the Company’s obligations under the Director Note.                        |

| (7) | For Mr. Friedberg,                                                                                                             
 includes 1,667 shares of Common Stock issuable upon the exercise stock options held by Mr. Friedberg, which are exercisable    
 for shares of Common Stock at a price of $226.80 per share, 9,705 shares of Common Stock issuable upon the exercise of a stock 
 option held by Mr. Friedberg, which are exercisable for shares of Common Stock at a price of $13.50 per share, an RSU for      
 6,474 shares, an RSU for 3,185 shares, 92,072 shares of Common Stock owned by Balmoral Financial Group LLC (“Balmoral”)        
 and 40,000 shares of Common Stock owned by Key Recovery Group LLC (“Key Recovery”). In addition, Mr. Friedberg                 
 serves as a manager with individual dispositive power of Balmoral and Key, and accordingly, may be deemed to beneficially      
 own the